sporogenics

Sporogenics filed a PCT patent on 10-Sep-2021 on ADHESION BARRIER COMPOSITION, METHODS OF FABRICATION AND USE THEREOF

Title (EN) ADHESION BARRIER COMPOSITION, METHODS OF FABRICATION AND USE THEREOF (FR) COMPOSITION DE BARRIÈRE ANTI-ADHÉRENCE, SES PROCÉDÉS DE FABRICATION ET SON UTILISATION Abstract (EN) The present invention relates, in general terms, to methods of reducing the formation of post-surgery tissue adhesion in a subject in need thereof by administering an adhesion barrier composition. The …

Sporogenics filed a PCT patent on 10-Sep-2021 on ADHESION BARRIER COMPOSITION, METHODS OF FABRICATION AND USE THEREOF Read More »

Sporogenics participated in MedTech Innovator APAC 2020

Among over 180 submissions, Sporogenics is delighted to be selected as one of the 40 medtech startups for an online pitch session on 26 May 2020 during the global pandemic due to COVID-19. It was a great learning experience interacting with industry experts such as from Johnson and Johnson, Baxter, Oliver Healthcare Packaging etc.

Baxter picks up Sanofi’s Seprafilm adhesion barrier for $350M

Dec 2, 2019 Baxter International said Monday it plans to acquire Sanofi’s surgical products unit Seprafilm and related assets for $350 million in cash, confirming October speculation the Deerfield, Illinois-based healthcare products company and French pharma were weighing a deal. The deal gives Baxter’s surgery division an adhesion barrier product meant to reduce incidence and …

Baxter picks up Sanofi’s Seprafilm adhesion barrier for $350M Read More »

Scroll to Top